<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">134</article-id>
      <article-id pub-id-type="doi">10.31348/2019/5/6</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intravitreal Therapy of Endogenous Endophthalmitis due to Urosepsis – A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Valášková</surname>
            <given-names>Jela</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-4740-2587</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sitárová</surname>
            <given-names>Jana</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krásnik</surname>
            <given-names>Vladimír</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>6</day>
        <month>4</month>
        <year>2020</year>
      </pub-date>
      <issue>5</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>This case report describes a case of endogenous endophthalmitis in a 58 year old man upon a background of urosepsis and bronchitis. The patient was hospitalised at a department of internal medicine in another hospital. The day after admittance he was sent to our clinic for a consultation examination due to worsening of vision and pain in the left eye. The condition was diagnosed as endogenous endophthalmitis. Visual acuity at the first examination was hand movement in front of the eye. Intravitreal therapy was commenced with a combination of two antibiotics (ceftazidime 2 mg/ 0.1 ml and vancomycin 1 mg/0.1 ml) and an antimycotic agent (amphotericin B 10 μg/0.1 ml). Over the course of two weeks the patient received this antibiotic treatment intravitreally 3x in total. During the first application of antibiotics, material was sampled from the anterior chamber of the eye for a microbiological examination – the result was negative. The blood culture tested positive for staphylococcus aureus. Intravenous application of antibiotics(gentamicin 240 mg i.v. every 24 hours and amoxicillin with clavulanic acid 1.2 g i.v. every 8 hours) was set for two weeks, and then antibiotic treatment continued (ciprofloxacin 500 mg every 12 hours) and antimycotic therapy (itraconazole 100 mg every 12 hours) orally for 2 months. Four weeks after the beginning of therapy, visual acuity in the left eye was 20/100 and after two months 20/40. The study emphasises the advantage of multi-disciplinary co-operation.</p>
      </abstract>
      <kwd-group>
        <kwd>endophtalmitis</kwd>
        <kwd>intravitreal therapy</kwd>
        <kwd>staphyloccocus aureus</kwd>
        <kwd>urosepsis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R7372">
        <mixed-citation>Agarwal, M., Biswas, J., Mathur, U. et al.: Aspergillus iris granuloma in a young male: a case report with review of literature. Indian J Ophthalmol, 55; 2007: 73-4.</mixed-citation>
      </ref>
      <ref id="R7373">
        <mixed-citation>Amphornphruet, A., Silpa-Archa, S., Preble, J.M. et al.: Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment. Ocul Immunol Inflamm, 26; 2018: 518-522.</mixed-citation>
      </ref>
      <ref id="R7374">
        <mixed-citation>Ang, M., Jap, A., Chee, S.P.: Prognostic factors and outcomes in endogenous Klebsiella pneumoniae endophthalmitis. Am J Ophthalmol, 151; 2011: 338-44 e2.</mixed-citation>
      </ref>
      <ref id="R7375">
        <mixed-citation>Buzzacco, D.M., Carroll, C.P.: Intravitreal daptomycin in a case of bilateral endogenous endophthalmitis. Arch Ophthalmol, 130; 2012: 940-1.</mixed-citation>
      </ref>
      <ref id="R7376">
        <mixed-citation>Connell, P.P., O’Neill, E.C., Fabinyi, D. et al.: Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond), 25; 2011: 66-72.</mixed-citation>
      </ref>
      <ref id="R7377">
        <mixed-citation>de Lima, L.M., Cecchetti, S.A., Cecchetti, D.F. et al.: Endophthalmitis: a rare but devastating metastatic bacterial complication of hemodialysis catheter-related sepsis. RenFail, 34; 2012: 119-22.</mixed-citation>
      </ref>
      <ref id="R7378">
        <mixed-citation>Durand, M.L.: Endophthalmitis. Clin Microbiol Infect, 19; 2013: 227-34.</mixed-citation>
      </ref>
      <ref id="R7379">
        <mixed-citation>Grixti, A., Sadri, M., Datta, A.V.: Uncommon ophthalmolo - gic disorders in intensive care unit patients. J Crit Care, 27; 2012: 746 e9-22.</mixed-citation>
      </ref>
      <ref id="R7380">
        <mixed-citation>Ho, V., Ho, L.Y., Ranchod, T.M. et al.: Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis. Retina, 31; 2011: 596-601.</mixed-citation>
      </ref>
      <ref id="R7381">
        <mixed-citation>Hu, C.C., Ho, J.D., Lou, H.Y. et al.: A one-year follow-up study on the incidence andrisk of endophthalmitis after pyogenic liver abscess. Ophthalmology, 119; 2012: 2358-63.</mixed-citation>
      </ref>
      <ref id="R7382">
        <mixed-citation>Chen, K.J., Chao, A.N., Hwang, Y.S. et al.: Prognostic factors and outcomes in endogenous Klebsiella endophthalmitis. Am J Ophthalmol, 151; 2011: 1105-6; author reply 1106-7.</mixed-citation>
      </ref>
      <ref id="R7383">
        <mixed-citation>Cheng, H.H., Ding, Y., Wu, M. et al.: Endogenous aspergillus endophthalmitis after kidney transplantation. Int J Ophthalmol, 4; 2011: 567-71.</mixed-citation>
      </ref>
      <ref id="R7384">
        <mixed-citation>Chhablani, J.: Fungal endophthalmitis. Expert Rev Anti Infect Ther, 9; 2011: 1191-201.</mixed-citation>
      </ref>
      <ref id="R7385">
        <mixed-citation>Jackson, T.L., Eykyn, S.J., Graham, E.M. et al.: Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol, 48; 2003: 403-23.</mixed-citation>
      </ref>
      <ref id="R7386">
        <mixed-citation>Jackson, T.L., Paraskevopoulos, T., Georgalas, I.: Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol, 59; 2014: 627-35.</mixed-citation>
      </ref>
      <ref id="R7387">
        <mixed-citation>Jung, J., Lee, J., Yu, S.N. et al.: Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother, 60; 2016: 2012-7.</mixed-citation>
      </ref>
      <ref id="R7388">
        <mixed-citation>Kansal, V., Rahimy, E., Garg, S. et al.: Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis secondary to axillary phlegmon: a case report. Can J Ophthalmol, 52; 2017: e97-e99.</mixed-citation>
      </ref>
      <ref id="R7389">
        <mixed-citation>Keyashian, K., Malani, P.N.: Endophthalmitis associated with intravenous drug use. South Med J, 100; 2007: 1219- 20.</mixed-citation>
      </ref>
      <ref id="R7390">
        <mixed-citation>Khan, F.A., Slain, D., Khakoo, R.A.: Candida endophthalmi - tis: focus on current and future antifungal treatment options. Pharmacotherapy, 27; 2007: 1711-21.</mixed-citation>
      </ref>
      <ref id="R7391">
        <mixed-citation>Lamaris, G.A., Esmaeli, B., Chamilos, G. et al.: Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis, 27; 2008: 343-7.</mixed-citation>
      </ref>
      <ref id="R7392">
        <mixed-citation>Lee, J.H., Kim, J.S., Park, Y.H.: Diagnosis and treatment of postpartum Candida endophthalmitis. J Obstet Gynaecol Res, 38; 2012: 1220-2.</mixed-citation>
      </ref>
      <ref id="R7393">
        <mixed-citation>Lim, H.W., Shin, J.W., Cho, H.Y. et al.: Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina, 34; 2014: 592-602.</mixed-citation>
      </ref>
      <ref id="R7394">
        <mixed-citation>Lingappan, A., Wykoff, C.C., Albini, T.A. et al.: Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol, 153; 2012: 162-6 e1.</mixed-citation>
      </ref>
      <ref id="R7395">
        <mixed-citation>Logan, S., Rajan, M., Graham, E. et al.: A case of aspergillus endophthalmitis in an immuncompetent woman: intra-ocular penetration of oral voriconazole: a case report. Cases J, 3; 2010: 31.</mixed-citation>
      </ref>
      <ref id="R7396">
        <mixed-citation>Lynn, W.A., Lightman, S.: The eye in systemic infection. Lan - cet, 364; 2004: 1439-50.</mixed-citation>
      </ref>
      <ref id="R7397">
        <mixed-citation>Mamandhar, A., Bajracharya, L.: Endogenous Aspergillus endophthalmitis in a healthy individual. Nepal J Ophthalmol, 4; 2012: 179-83.</mixed-citation>
      </ref>
      <ref id="R7398">
        <mixed-citation>Novosad, B.D., Callegan, M.C.: Severe bacterial endophthal - mitis: towards improving clinical outcomes. Expert Rev Ophthalmol, 5; 2010: 689-698.</mixed-citation>
      </ref>
      <ref id="R7399">
        <mixed-citation>Oude Lashof, A.M., Rothova, A., Sobel, J.D. et al.: Ocular manifestations of candidemia. Clin Infect Dis, 53; 2011: 262- 8.</mixed-citation>
      </ref>
      <ref id="R7400">
        <mixed-citation>Radhika, M., Mithal, K., Bawdekar, A. et al.: Pharmacokinetics of intravitreal antibiotics in endophthalmitis. J Ophthalmic Inflamm Infect, 4; 2014: 22.</mixed-citation>
      </ref>
      <ref id="R7401">
        <mixed-citation>Reedy, J.S., Wood, K.E.: Endogenous Pseudomonas aeruginosa endophthalmitis: a case report and literature review. Intensive Care Med, 26; 2000: 1386-9.</mixed-citation>
      </ref>
      <ref id="R7402">
        <mixed-citation>Rodrigues, I.A., Jackson, T.L.: A high-definition view of endogenous fungal endophthalmitis. Lancet Infect Dis, 14; 2014: 358.</mixed-citation>
      </ref>
      <ref id="R7403">
        <mixed-citation>Sahu, C., Kumar, K., Sinha, M.K. et al.: Review of endogenous endophthalmitis during pregnancy including case series. Int Ophthalmol, 33; 2013: 611-8.</mixed-citation>
      </ref>
      <ref id="R7404">
        <mixed-citation>Shankar, K., Gyanendra, L., Hari, S. et al.: Culture proven endogenous bacterial endophthalmitis in apparently healthy individuals. Ocul Immunol Inflamm, 17; 2009: 396-9.</mixed-citation>
      </ref>
      <ref id="R7405">
        <mixed-citation>Sharma, S., Padhi, T.R., Basu, S. et al.: Endophthalmitis patients seen in a tertiary eye care centre in Odisha: a clinicomicrobiological analysis. Indian J Med Res, 139; 2014: 91-8.</mixed-citation>
      </ref>
      <ref id="R7406">
        <mixed-citation>Sheu, S.J., Kung, Y.H., Wu, T.T. et al.: Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina, 31; 2011: 2026-31.</mixed-citation>
      </ref>
      <ref id="R7407">
        <mixed-citation>Schiedler, V., Scott, I.U., Flynn, H.W., Jr. et al.: Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol, 137; 2004: 725-31.</mixed-citation>
      </ref>
      <ref id="R7408">
        <mixed-citation>Sridhar, J., Flynn, H.W., Jr., Kuriyan, A.E. et al.: Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect, 3; 2013: 60.</mixed-citation>
      </ref>
      <ref id="R7409">
        <mixed-citation>Steeples, L.R., Jones, N.P.: Staphylococcal endogenous endophthalmitis in association with pyogenic vertebral osteomyelitis. Eye (Lond), 30; 2016: 152-5.</mixed-citation>
      </ref>
      <ref id="R7410">
        <mixed-citation>Tong, S.Y., Davis, J.S., Eichenberger, E. et al.: Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev, 28; 2015: 603-61.</mixed-citation>
      </ref>
      <ref id="R7411">
        <mixed-citation>Tsai, A.S., Lee, S.Y., Jap, A.H.: An unusual case of recurrent endogenous Klebsiella endophthalmitis. Eye (Lond), 24; 2010: 1630-1.</mixed-citation>
      </ref>
      <ref id="R7412">
        <mixed-citation>Vergoulidou, M., Krause, L., Foerster, M.H. et al.: Endogenous filamentous fungal endophthalmitis--single-centre survey in patients with acute leukaemia or postallogeneic stem cell transplantation and review of the literature. Mycoses, 54; 2011: e704-11.</mixed-citation>
      </ref>
      <ref id="R7413">
        <mixed-citation>Vilela, R.C., Vilela, L., Vilela, P. et al.: Etiological agents of fungal endophthalmitis: diagnosis and management. Int Ophthalmol, 34; 2014: 707-21.</mixed-citation>
      </ref>
      <ref id="R7414">
        <mixed-citation>Wu, A.Y., Oestreicher, J.H.: Endogenous bacterial endophthalmitis after routine colonoscopy. Can J Ophthalmol, 46; 2011: 556-7.</mixed-citation>
      </ref>
      <ref id="R7415">
        <mixed-citation>Wu, Z.H., Chan, R.P., Luk, F.O. et al.: Review of Clinical Features, Microbiological Spectrum, and Treatment Outcomes of Endogenous Endophthalmitis over an 8-Year Period. J Ophthalmol, 2012; 2012: 265078.</mixed-citation>
      </ref>
      <ref id="R7416">
        <mixed-citation>Yonekawa, Y., Chan, R.V., Reddy, A.K. et al.: Early intravitreal treatment of endogenous bacterial endophthalmitis. Clin Exp Ophthalmol, 39; 2011: 771-8.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
